| scholarly article | Q13442814 |
| P50 | author | Mark Lathrop | Q6768494 |
| Dominique Gauguier | Q42675344 | ||
| P2093 | author name string | A Gonzalez | |
| H Ji | |||
| V Duchatelle | |||
| C Benoist | |||
| D Mathis | |||
| K Ohmura | |||
| C Degott | |||
| H J Garchon | |||
| P Danoy | |||
| P2860 | cites work | The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes | Q24805318 |
| Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice | Q28272701 | ||
| Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results | Q29547377 | ||
| Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins | Q31460983 | ||
| Overview of QTL mapping software and introduction to map manager QT. | Q33543794 | ||
| Mapping autoimmunity genes | Q33814985 | ||
| From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins | Q33860728 | ||
| Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease | Q33940942 | ||
| The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes | Q34104677 | ||
| Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon | Q34433110 | ||
| Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis | Q35834623 | ||
| Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases | Q36282160 | ||
| Identification of rat susceptibility loci for adjuvant-oil-induced arthritis | Q37411060 | ||
| New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. | Q37486377 | ||
| Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity | Q38666665 | ||
| Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis | Q42616306 | ||
| Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg genes on chromosome 1 | Q42620654 | ||
| Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. | Q50850183 | ||
| A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. | Q54023198 | ||
| Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. | Q54113921 | ||
| Genetic linkage analysis of collagen-induced arthritis in the mouse. | Q54117646 | ||
| Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. | Q54120727 | ||
| T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse. | Q54294476 | ||
| Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum | Q56966725 | ||
| Structure of the mouse beta Fc gamma receptor II gene | Q56967268 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| Identification of a new quantitative trait locus on Chromosome 7 controlling disease severity of collagen-induced arthritis in rats | Q57533104 | ||
| A genome scan localizes five non–MHC loci controlling collagen–induced arthritis in rats | Q57533119 | ||
| Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease | Q69691722 | ||
| Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice | Q69965577 | ||
| Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice | Q70495194 | ||
| Organ-specific disease provoked by systemic autoimmunity | Q71838378 | ||
| Genetic epidemiology of rheumatoid arthritis | Q71878284 | ||
| Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme | Q73216181 | ||
| Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B | Q73330382 | ||
| Functional dissection of systemic lupus erythematosus using congenic mouse strains | Q73433330 | ||
| Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction | Q73441077 | ||
| Genetic control of diabetes progression | Q74045636 | ||
| Genetic control of susceptibility to collagen-induced arthritis in T cell receptor beta-chain transgenic mice | Q74251338 | ||
| A critical role for complement in maintenance of self-tolerance | Q77658426 | ||
| Identification of the gene loci that predispose to rheumatoid arthritis | Q77786365 | ||
| Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat | Q78145308 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 321-330 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Genetic influences on the end-stage effector phase of arthritis | |
| P478 | volume | 194 |
| Q41128092 | 11β-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice |
| Q33299576 | A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis |
| Q46717395 | A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis |
| Q33354118 | A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. |
| Q34998962 | A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis |
| Q37087771 | A transmembrane polymorphism in FcgammaRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA. |
| Q37326948 | Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice |
| Q46217420 | An autoantibody in narcolepsy disrupts colonic migrating motor complexes. |
| Q36718541 | Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis |
| Q43899243 | Arthritis critically dependent on innate immune system players |
| Q53003745 | Arthritis induced with cartilage-specific antibodiesis IL-4-dependent. |
| Q36370135 | Arthritogenic monoclonal antibodies from K/BxN mice |
| Q34265750 | Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis |
| Q36907740 | Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade. |
| Q36842971 | Autoreactive T and B cells induce the development of bronchus-associated lymphoid tissue in the lung |
| Q36955312 | Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis |
| Q44967035 | Citrullination of self-proteins and autoimmunity |
| Q37055162 | Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita |
| Q55050150 | Complement in the Initiation and Evolution of Rheumatoid Arthritis. |
| Q47155344 | Complement-targeted therapy: development of C5- and C5a-targeted inhibition |
| Q35092551 | Congenic mice: cutting tools for complex immune disorders |
| Q36912113 | Contribution of genetic studies in rodent models of autoimmune arthritis to understanding and treatment of rheumatoid arthritis |
| Q36371110 | Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis |
| Q45024317 | Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis |
| Q43918931 | Dynamic visualization of a joint-specific autoimmune response through positron emission tomography |
| Q36371879 | Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis |
| Q79889546 | Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis |
| Q33939470 | Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide |
| Q34162118 | Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury |
| Q35086874 | Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse |
| Q36021530 | Genome-wide and species-wide dissection of the genetics of arthritis severity in heterogeneous stock mice |
| Q46111725 | Genome-wide search for genes that modulate inflammatory arthritis caused by Ali18 mutation in mice |
| Q37087686 | Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). |
| Q40021352 | Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis |
| Q38359753 | High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis |
| Q43918929 | How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q34401702 | IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis |
| Q24812914 | Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase |
| Q36232651 | Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis |
| Q41857082 | Innate immunity as a hired gun: but is it rheumatoid arthritis? |
| Q36370656 | Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling |
| Q34438110 | JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis |
| Q26745541 | K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis |
| Q42276145 | K/BxN serum transfer arthritis as a model of inflammatory joint pain |
| Q38754245 | KRN/I-Ag7 mouse arthritis is independent of complement C3. |
| Q34637340 | Lessons from animal models of arthritis |
| Q37994660 | Mapping pathogenesis of arthritis through small animal models |
| Q33790174 | Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis. |
| Q85062884 | Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis |
| Q63433140 | Mouse models for rheumatoid arthritis |
| Q33840418 | NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis |
| Q36402567 | NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production |
| Q35170050 | Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model |
| Q33404086 | PECAM-independent thioglycollate peritonitis is associated with a locus on murine chromosome 2 |
| Q38810372 | Pain in rheumatoid arthritis: models and mechanisms. |
| Q38828545 | Pharmacological Value of Murine Delayed-type Hypersensitivity Arthritis: A Robust Mouse Model of Rheumatoid Arthritis in C57BL/6 Mice |
| Q36735401 | Primer: comparative genetics of animal models of arthritis--a tool to resolve complexity |
| Q36392288 | Pro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis. |
| Q33667772 | Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis |
| Q92543466 | Recent Advances in Allergy Research Using Humanized Mice |
| Q36939396 | Rheumatoid arthritis and the complement system. |
| Q34701028 | Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone |
| Q35788463 | TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis |
| Q56797384 | The Inhibitory Co-Receptor, PECAM-1 Provides a Protective Effect in Suppression of Collagen-Induced Arthritis |
| Q28573570 | The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion |
| Q36624577 | The complex role of Fcgamma receptors in the pathology of arthritis |
| Q37340475 | The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity |
| Q41895580 | The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis |
| Q40962777 | The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita |
| Q24799403 | The role and clinical implications of G6PI in experimental models of rheumatoid arthritis |
| Q35216978 | The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus |
| Q89181533 | The role of neutrophil extracellular traps in rheumatic diseases |
| Q24817177 | The role of the complement and the Fc gamma R system in the pathogenesis of arthritis |
| Q35103501 | Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis |
| Q33933930 | Variation in IL-1beta gene expression is a major determinant of genetic differences in arthritis aggressivity in mice |
| Q35785711 | Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis |
Search more.